AGP Executive Report
Last update: an hour agoMarijuana rescheduling: A key U.S. federal deadline is set for Monday in the process to move marijuana from Schedule I to Schedule III, with optional post-hearing briefs due and a recommendation expected before any final DEA decision—potentially reshaping research and patient access. Medical access gap: A Rutgers Health study finds most adults over 65 rarely discuss cannabis with clinicians, and only about one in three report being screened—despite rising use among older adults. Hawaii hemp crackdown fight: Hawaiʻi’s Department of Health has moved to restrict hemp-derived THC products sold without medical marijuana cards, and one retailer is suing to stop the crackdown, arguing the state is re-criminalizing federally legal hemp. Clinical trial signal: A report highlights oral CBD helping with post-surgery ocular pain as effectively as opioids, adding to the growing medical case for CBD-based treatment options. Policy pressure on hemp products: Separate coverage notes ongoing legal and political friction around hemp and cannabis rules, including challenges tied to federal implementation and state-level enforcement.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
